Development and evaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens
- PMID: 18400916
- PMCID: PMC2446872
- DOI: 10.1128/JCM.01858-07
Development and evaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens
Abstract
The ResPlex I assay (Qiagen) was designed to amplify and detect DNA of six bacterial respiratory pathogens. This assay was compared with real-time PCR assays based upon the same target sequences for the ability detect the target bacteria by use of both stock strains and specimens from respiratory disease patients. The ResPlex I assay is somewhat less sensitive than real-time PCR assays but offers the advantage of multiple assays in a single reaction.
References
-
- Bustin, S. A. (ed.) 2004. A-Z of quantitative PCR. International University Line, La Jolla, CA.
-
- Carvalho, M. G. S., M. L. Tondella, K. McCaustland, L. Weidlich, L. McGee, L. W. Mayer, A. Steigerwalt, M. Whaley, R. R. Facklam, B. Fields, G. Carlone, E. W. Ades, R. Dagan, and J. S. Sampson. 2007. Evaluation and improvement of real-time PCR detection assays to lytA, ply, and psaA genes for detection of pneumococcal DNA. J. Clin. Microbiol. 452460-2466. - PMC - PubMed
-
- Centers for Disease Control and Prevention. 1997. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 46(RR-8)1-24. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
